Ausgabe 6/2002
Inhalt (11 Artikel)
A protein kinase C inhibitor induces phenotypic reversion of ras-transformed pancreatic cancer cells and cooperatively blocks tumor cell proliferation with an anti-ras peptide
Denise Way, Steven Smith, Sharmila Sivendran, Lyndon Chie, Mecheal Kanovsky, Paul W. Brandt-Rauf, Denise L. Chung, Josef Michl, Matthew R. Pincus
Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells
Dorte Nielsen, Jens Eriksen, Christian Maare, Ellen Friche, Torben Skovsgaard
Overexpression of Bax sensitizes human pancreatic cancer cells to apoptosis induced by chemotherapeutic agents
Zhong-Wei Xu, Helmut Friess, Markus W. Büchler, Marc Solioz
Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients
Raul C. Maranhão, Silvia R. Graziani, Nise Yamaguchi, Roberto F. Melo, Maria C. Latrilha, Debora G. Rodrigues, Ricardo D. Couto, Shirley Schreier, Antonio C. Buzaid
Differential cytostatic effect of sodium salicylate in human colorectal cancers using an individualized histoculture system
Yanqun Liu, Kong Eu, Francis Seow-Choen, Peh Cheah
Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model
Pierre Marchettini, Anthony O. Stuart, Faheez Mohamed, Dal Yoo, Paul H. Sugarbaker
Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents
Jean-Marc Barret, Anna Kruczynski, Chantal Etiévant, Bridget T. Hill
Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins
Catherine Sergent, Noreli Franco, Caroline Chapusot, Sarab Lizard-Nacol, Nicolas Isambert, Maria Correia, Bruno Chauffert
Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles
Iwao Iwasaki, Hisahiko Sugiyama, Shinsaku Kanazawa, Hiromichi Hemmi
Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA
P. Jacobson, K. Green, A. Birnbaum, R. Remmel
Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase II study of patients with breast cancer
Gyo Asai, Nobuyuki Yamamoto, Masakazu Toi, Eisei Shin, Kiyoshi Nishiyama, Tomohisa Sekine, Yasuo Nomura, Shigemitsu Takashima, Morihiko Kimura, Takeshi Tominaga